MFN Partners Management, LP Diversified Active

CIK: 0001732811 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $629,936 (100.0% shares, 0.0% debt)

Holdings (17)

ALLERGAN PLC 23.9%
Value ($000) $150,704 Shares 900,101 Est. Cost $143.04 Unrealized
FOXA FOX CORP 13.8%
Value ($000) $86,812 Shares 2,369,331 Est. Cost $35.41 Unrealized -5.2%
PCG PG&E CORP 10.2%
Value ($000) $64,176 Shares 2,800,000 Est. Cost $21.11 Unrealized -5.9%
IRWD IRONWOOD PHARMACEUTICALS INC 8.6%
Value ($000) $54,039 Shares 4,939,541 Est. Cost $11.48 Unrealized -2.4%
XPO XPO LOGISTICS INC 8.4%
Value ($000) $52,835 Shares 913,935 Est. Cost $27.03 Unrealized -24.6%
LNG CHENIERE ENERGY INC 8.1%
Value ($000) $51,338 Shares 750,000 Est. Cost $61.54 Unrealized +7.6%
GS GOLDMAN SACHS GROUP INC 5.6%
Value ($000) $35,562 Shares 173,811 Est. Cost $170.89 Unrealized -1.0%
PIONEER NAT RES CO 4.9%
Value ($000) $30,772 Shares 200,000 Est. Cost $131.52 Unrealized
FGL HLDGS 4.0%
Value ($000) $25,200 Shares 3,000,000 Est. Cost $7.72 Unrealized
GTT COMMUNICATIONS INC 3.5%
Value ($000) $22,000 Shares 1,250,000 Est. Cost $22.45 Unrealized
CYCLERION THERAPEUTICS INC 2.7%
Value ($000) $17,036 Shares 1,487,874 Est. Cost $11.45 Unrealized
LIBERTY GLOBAL PLC 2.6%
Value ($000) $16,596 Shares 625,558 Est. Cost $26.53 Unrealized
TAK TAKEDA PHARMACEUTICAL CO LTD 2.2%
Value ($000) $13,895 Shares 785,000 Est. Cost $20.37 Unrealized
NAVI NAVIENT CORPORATION 0.5%
Value ($000) $3,335 Shares 244,300 Est. Cost $11.45 Unrealized +13.9%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value ($000) $3,285 Shares 1,500,000 Est. Cost $10.31 Unrealized -47.1%
EOLS EVOLUS INC 0.3%
Value ($000) $1,754 Shares 120,000 Est. Cost $19.82 Unrealized 0.0%
REVANCE THERAPEUTICS INC 0.1%
Value ($000) $597 Shares 46,000 Est. Cost $20.13 Unrealized